MYLAN-MIRTAZAPINE
MYLAN PHARMACEUTICALS ULC
Quick answers
Is there a shortage of MYLAN-MIRTAZAPINE in Canada?
No. There is no current shortage of MYLAN-MIRTAZAPINE 30MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
REMERON
ORGANON CANADA INC.
RATIO-MIRTAZAPINE
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
RIVA-MIRTAZAPINE
LABORATOIRE RIVA INC.
CO MIRTAZAPINE
COBALT PHARMACEUTICALS COMPANY
NTP-MIRTAZAPINE
TEVA CANADA LIMITED
SANDOZ MIRTAZAPINE
SANDOZ CANADA INCORPORATED
DIN
02256118
Strength
30MG
Dosage Form
TABLET
Route
ORAL
Compare with another product →
Shortage History
Demand increase for the drug.
Disruption of the manufacture of the drug.
Other Products from MYLAN PHARMACEUTICALS ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
500MG · DIN 02385473
333MG · DIN 02293269
40MG · DIN 02257963
10MG · DIN 02257955
DIN 02388138
DIN 02388146
50MG · DIN 02468549
2G · DIN 02407310
1G · DIN 02407302
12.5MG · DIN 02554631
50MG · DIN 02554666
25MG · DIN 02247243